chemmedchem
compound
open
e
ring
figur
ii
oxid
posit
figur
iii
demonstr
lower
activ
discov
novel
antivir
agent
denv
seri
lycorin
deriv
synthes
assay
studi
structureact
relationship
respect
antidenv
activ
dengu
fever
current
global
health
threat
dengu
transmiss
ubiquit
throughout
tropic
highest
risk
zone
america
asia
estim
million
dengu
infect
annual
pathogen
dengu
fever
dengu
viru
denv
singlestrand
rna
viru
belong
flaviviru
genu
denv
transmit
aed
aegypti
four
serotyp
denv
serotyp
caus
mild
dengu
fever
case
lead
lifethreaten
complic
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
dhf
dss
repres
sever
form
diseas
denv
infect
commonli
report
children
symptom
denv
infect
includ
fever
low
platelet
count
hemorrhag
bleed
vascular
permeabl
current
effect
antivir
therapi
vaccin
denv
infect
avail
need
simultan
immun
induc
longlast
protect
four
serotyp
pose
particular
challeng
develop
vaccin
therefor
continu
increas
need
develop
effect
antivir
agent
denv
lycorin
figur
one
major
alkaloid
isol
amaryllidacea
famili
plant
possess
divers
biolog
properti
includ
anticanc
antiplasmodi
antitrypanosom
antiinflammatori
analges
emet
properti
lycorin
also
report
demonstr
broadspectrum
inhibitori
activ
sever
virus
polioviru
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
herp
simplex
viru
type
vaccinia
viru
bunyavirus
punta
toro
viru
rift
valley
fever
viru
lycorin
previous
shown
potent
inhibit
flavivirus
vitro
model
lycorin
reduc
viral
titer
west
nile
viru
wnv
denv
yellow
fever
viru
yfv
fold
concentr
mm
lycorin
primarili
exert
activ
suppress
viral
rna
replic
mutagenesi
studi
reveal
singl
amino
acid
substitut
peptid
span
endoplasm
reticulum
membran
protein
howev
whether
peptid
direct
target
lycorin
remain
determin
addit
synthes
lycorin
deriv
investig
inhibitori
activ
wnv
preliminari
structureact
relationship
studi
indic
modif
hydroxi
group
posit
reduc
cytotox
wherea
oxid
group
figur
slightli
increas
potenc
dengu
system
viral
infect
transmit
human
aed
mosquito
vaccin
specif
therapeut
current
avail
dengu
lycorin
natur
plant
alkaloid
shown
possess
antivir
activ
flavivirus
studi
seri
novel
lycorin
deriv
synthes
assay
inhibit
dengu
viru
denv
cell
cultur
among
lycorin
analogu
exhibit
potent
antidenv
activ
ec
mm
reduc
cytotox
cc
mm
result
select
index
cc
ec
keton
ec
mm
ec
mm
also
exhibit
excel
antivir
activ
low
cytotox
structureact
relationship
lycorin
deriv
denv
discuss
threedimension
quantit
structureact
relationship
model
establish
use
compar
molecularfield
analysi
protocol
order
ration
experiment
result
modif
hydroxi
group
posit
retent
keton
posit
could
potenti
lead
inhibitor
improv
overal
properti
chemistri
lycorin
commerci
avail
hydrochlorid
salt
due
poor
solubl
organ
solvent
deriv
contain
are
modif
synthes
form
high
yield
acetyl
hydroxi
group
acet
anhydrid
presenc
pyridin
scheme
ring
ring
open
use
boron
tribromid
follow
acetyl
acet
anhydrid
produc
acetyl
group
remov
hclmethanol
treatment
treat
differ
keton
afford
seri
deriv
contain
variou
function
ring
nitro
group
reduc
amino
group
use
hydrazin
monohydr
produc
scheme
sever
deriv
synthes
investig
influenc
modif
group
scheme
select
deacetyl
posit
hcl
methanol
afford
ester
prepar
reaction
differ
acyl
chlorid
presenc
pyridin
addit
treatment
glutar
anhydrid
dichloromethan
produc
deriv
diphenylphosphoryl
azid
dppa
condens
agent
bocglycin
react
produc
mitsunobu
reaction
appli
order
furnish
subsequ
convert
deprotect
hydrazin
monohydr
invers
configur
confirm
use
nosey
analysi
provid
correl
peak
figur
group
easili
oxid
swern
condit
afford
desir
keton
good
yield
moreov
obtain
heat
concentr
hcl
methanol
deriv
variou
modif
posit
form
introduct
epoxid
allyl
alcohol
posit
scheme
epoxid
ring
introduc
twostep
reaction
product
possess
tran
configur
epoxid
ring
azid
ether
obtain
open
epoxid
correspond
nucleophil
reagent
nucleophil
attack
epoxid
occur
least
hinder
side
high
regioselect
afford
similar
previou
report
base
bioisoster
intend
convert
hydroxi
group
posit
amino
group
obtain
reduct
azid
group
lithium
aluminum
hydrid
thf
triazol
ring
introduc
lycorin
appli
click
chemistri
afford
deriv
group
reactiv
group
due
allyl
natur
therefor
group
select
modifi
use
differ
chlorid
reagent
yield
compound
configur
confirm
use
nosey
analysi
correl
peak
found
correl
observ
figur
b
group
reactiv
group
hydroxi
group
posit
must
convert
function
group
first
protect
investig
influenc
modif
oxid
product
contain
free
group
select
start
materi
reaction
divers
acyl
chlorid
reagent
produc
deriv
scheme
previou
studi
shown
lycorin
potent
inhibit
denv
wnv
yfv
cell
cultur
goal
studi
investig
influenc
are
modif
lycorin
substitut
group
activ
denv
antidenv
activ
lycorin
deriv
evalu
use
vitro
cellbas
flaviviru
immunodetect
cfi
assay
result
express
ec
valu
antivir
activ
cc
valu
cytotox
tabl
et
al
report
dissect
ring
decreas
antiplasmodi
activ
lycorin
deriv
similarli
two
deriv
open
are
demonstr
dramat
loss
antidenv
activ
variou
keton
use
rebuild
ring
differ
substitu
methylen
group
yield
howev
none
deriv
exhibit
antivir
activ
evalu
concentr
mm
tabl
support
inform
result
indic
requir
ring
potenc
intoler
substitut
methylen
group
ring
biolog
analysi
reveal
potenc
ec
mm
two
time
lycorin
ec
mm
significantli
decreas
cytotox
cc
mm
result
si
valu
greater
therefor
sar
studi
initi
focu
modif
retent
ester
henc
select
chemic
start
point
modif
group
gener
studi
effect
antidenv
activ
tabl
comparison
esterif
product
indic
esterif
group
gener
result
reduct
antivir
activ
potenc
ester
decreas
increas
length
carbon
chain
interestingli
carboxyl
acid
ec
mm
carbam
ec
mm
introduc
terminu
aliphat
ester
chain
improv
activ
achiev
comparison
ec
mm
contain
modif
ester
contain
bulki
aliphat
group
tertbutyl
group
demonstr
less
potenc
acetyl
ester
addit
deriv
contain
aromat
substitut
group
posit
exhibit
less
potenc
chiral
posit
chang
r
use
mitsunobu
reaction
produc
analogu
decreas
activ
suggest
stereochemistri
may
influenc
activ
lycorin
deriv
denv
tabl
howev
impact
modif
hydroxi
group
exclud
therefor
influenc
chiral
posit
remain
address
futur
studi
oxid
group
carbonyl
group
report
slightli
increas
antiwnv
activ
significantli
reduc
cytotox
studi
oxid
deriv
exhibit
slightli
lower
potenc
ec
mm
cytotox
dramat
reduc
cc
mm
si
valu
greater
effort
explor
modif
retain
ester
led
discoveri
keton
exhibit
low
micromolar
inhibit
denv
signific
reduct
cytotox
remov
acetyl
ester
posit
led
ec
mm
cc
mm
si
exhibit
slightli
higher
antidenv
potenc
less
cytotox
lycorin
ec
mm
cc
mm
si
tabl
hydroxi
group
posit
retain
substitut
rel
broad
structur
featur
posit
investig
hydroxi
group
posit
convert
variou
function
group
includ
azid
amino
ether
ester
amid
triazol
siloxan
carboxyl
group
gener
functionalgroup
transform
group
result
loss
activ
tabl
ester
ether
siloxan
deriv
result
better
activ
amino
azid
amid
triazol
deriv
among
seri
base
bioisoster
hydroxi
group
posit
could
potenti
convert
amino
group
howev
amino
deriv
much
less
activ
lycorin
azid
amid
deriv
antidenv
activ
triazol
deriv
also
dramat
decreas
overal
result
suggest
group
play
import
role
antidenv
activ
keton
exhibit
rel
improv
antivir
properti
impact
modifi
substitu
retain
keton
posit
investig
acyl
group
yield
ester
evalu
biolog
properti
indic
linear
aliphat
chain
substitut
posit
result
improv
antivir
activ
rel
bulki
aromat
substitut
tabl
among
linear
aliphat
ester
inhibitor
shorter
carbon
chain
less
cytotox
although
inhibitori
activ
denv
similar
achiev
quantit
understand
relationship
denv
inhibitori
activ
molecular
structur
synthes
lycorin
deriv
threedimension
quantit
structureact
relationship
studi
perform
use
compar
molecularfield
analysi
comfa
protocol
implement
tripo
sybylx
softwar
herein
discuss
influenc
modif
andor
posit
total
compound
select
qsar
studi
deriv
exclud
qsar
analysi
compound
contain
signific
conform
chang
number
insuffici
yield
meaning
analysi
ester
chosen
templat
high
inhibitori
activ
sampl
partialleastsquar
sampl
analysi
method
use
linearli
correl
comfa
field
inhibitori
activ
valu
crossvalid
analysi
perform
use
leaveoneout
loo
method
one
compound
remov
dataset
activ
predict
use
model
deriv
remaind
dataset
crossvalid
conven
tional
correl
coeffici
r
result
optimum
number
compon
onc
lowest
standard
error
predict
consid
analysi
pl
result
comfa
model
summar
tabl
experiment
versu
predict
pec
valu
summar
tabl
support
inform
graphic
depict
figur
crossvalid
coeffici
q
indic
predict
capac
convent
correl
coeffici
r
indic
selfconsist
two
pivot
paramet
evalu
qualiti
pl
statist
q
valu
consid
signific
case
signific
correl
trial
comfa
model
use
studi
q
r
valu
respect
pl
result
indic
comfa
model
demonstr
good
predict
abil
shown
tabl
contribut
steric
electrostat
field
respect
indic
sar
andor
posit
influenc
steric
effect
electrostat
effect
comfa
contour
map
steric
field
present
figur
green
contour
indic
favor
region
steric
bulki
group
wherea
yellow
contour
indic
less
favor
region
bulki
group
phenomenon
observ
compound
inhibitori
activ
decreas
accord
length
aliphat
chain
posit
comfa
stericfield
contour
map
compound
gradual
extend
yellow
region
contrast
comfa
stericfield
contour
map
compound
lie
near
green
area
therefor
compound
exhibit
rel
high
potenc
moreov
flexibl
carbon
linear
chain
result
contour
green
region
near
posit
yield
improv
activ
rel
aromat
substitut
found
yellow
region
similarli
comfa
contour
map
electrostat
field
figur
b
bluer
region
favor
posit
neg
charg
group
respect
exampl
possess
higher
potenc
electronwithdraw
group
cl
may
increas
posit
charg
phenyl
ring
contrast
result
com
summari
seri
lycorin
deriv
synthes
evalu
denv
cellular
assay
compound
ec
mm
found
potent
antivir
agent
demonstr
best
si
valu
deriv
ec
mm
ec
mm
also
exhibit
excel
inhibitori
activ
low
cytotox
structureact
relationship
lycorin
deriv
denv
investig
modif
group
retent
keton
posit
could
potenti
lead
inhibitor
improv
overal
properti
model
use
comfa
protocol
establish
ration
experiment
result
gener
solvent
treat
use
standard
techniqu
use
reagent
purchas
commerci
supplier
use
without
purif
cfi
assay
perform
previous
describ
briefli
cell
infect
multipl
infect
presenc
twofold
serial
dilut
test
compound
incub
h
viral
antigen
product
quantifi
immun
detect
antibodi
goat
antimous
immunoglobulin
g
conjug
horseradish
peroxidas
primari
secondari
antibodi
respect
concentr
compound
decreas
viral
envelop
protein
product
ec
calcul
use
nonlinear
regress
analysi
total
compound
use
gener
model
structur
construct
sybylx
sketcher
assign
charg
follow
energi
minim
use
tripo
forc
field
prior
store
sybyl
databas
databas
align
subsequ
perform
base
lycorin
scaffold
compound
use
templat
high
potenc
biolog
activ
ec
valu
unit
mol
l
convert
neg
logarithm
pec
valu
merg
compound
databas
comfa
method
appli
perform
analysi
use
sybylx
softwar
comfa
region
automat
gener
method
gener
singl
lattic
overlap
includ
compound
extend
least
along
axe
energi
cutoff
valu
kcal
mol
set
steric
electrostat
interact
addit
comfa
field
pl
use
gener
linear
regress
correl
descriptor
inhibitori
activ
subsequ
crossvalid
perform
use
loo
methodolog
obtain
onc
predict
abil
correl
coeffici
q
calcul
compon
subsequ
noncrossvalid
perform
compon
obtain
r
valu
ad
dropwis
solut
mg
mmol
anhydr
ch
cl
ml
mixtur
stir
h
meoh
ml
slowli
ad
quench
reaction
solvent
remov
vacuo
crude
residu
dissolv
anhydr
pyridin
ml
follow
addit
ac
ml
mixtur
stir
rt
overnight
solvent
remov
vacuo
follow
addit
ch
cl
ml
water
ml
organ
layer
wash
satur
aq
nahco
brine
dri
anhydr
na
solut
concentr
crude
residu
purifi
use
silica
gel
chromatographi
etoacch
oh
yield
pale
yellow
solid
mg
gener
procedur
anhydr
keton
equiv
ptsoh
equiv
ad
solut
meoh
ml
mixtur
heat
h
solvent
remov
vacuo
follow
addit
ch
cl
ml
water
ml
organ
layer
dri
anhydr
na
filter
filtrat
concentr
crude
residu
purifi
use
silica
gel
chromatographi
yield
product
gener
procedur
acyl
chlorid
anhydrid
equiv
anhydr
ch
cl
ml
slowli
ad
solut
equiv
anhydr
pyridin
ml
min
solut
stir
tlc
analysi
indic
start
materi
consum
subsequ
ch
cl
ml
water
ml
ad
organ
layer
wash
satur
aq
nahco
brine
dri
anhydr
na
filter
filtrat
concentr
vacuo
crude
residu
purifi
use
silica
gel
chromatographi
petroleum
etheretoac
yield
product
glutar
acid
lycorin
glutar
anhydrid
mg
mmol
ad
solut
mg
mmol
ch
cl
ml
mixtur
stir
min
solvent
remov
vacuo
crude
residu
purifi
use
silica
gel
chromatographi
ch
cl
ch
oh
yield
white
solid
mg
bocgli
lycorin
dppa
g
mmol
nahco
g
mmol
ad
solut
g
mmol
bocglycin
g
mmol
dmf
ml
mixtur
stir
overnight
filter
filtrat
concentr
vacuo
crude
residu
purifi
use
silica
gel
chromatographi
petroleum
etheretoac
r
nhydroxyphthalimidelycorin
triphenylphosphin
mg
mmol
nhydroxyphthalimid
mg
mmol
ad
solut
mg
mmol
anhydr
thf
ml
follow
dropwis
addit
diethylazodicarboxyl
mg
mmol
mixtur
stir
rt
h
solvent
remov
vacuo
follow
addit
ch
cl
ml
water
ml
dmso
ml
mmol
anhydr
ch
cl
ml
ad
dropwis
solut
cocl
ml
mmol
anhydr
ch
cl
ml
mixtur
stir
min
follow
slow
addit
mg
mmol
anhydr
ch
cl
ml
reaction
stir
addit
h
follow
addit
et
n
ml
mmol
mixtur
stir
addit
min
brine
ml
ad
quench
reaction
solvent
remov
vacuo
follow
addit
ch
cl
ml
water
ml
organ
layer
wash
satur
aq
nahco
ml
brine
ml
dri
anhydr
na
filter
filtrat
concentr
crude
residu
purifi
use
silica
gel
chromatographi
petroleum
etheretoac
gener
procedur
phenylacetylen
mmol
cuso
mg
mmol
lascorb
acid
mg
mmol
ad
solut
mg
mmol
thf
ml
water
ml
mixtur
stir
rt
overnight
solut
basifi
ph
satur
aq
nahco
follow
addit
ch
cl
ml
water
ml
organ
layer
dri
anhydr
na
filter
filtrat
concentr
vacuo
crude
residu
purifi
use
silica
gel
chromatographi
yield
product
lycorin
follow
previous
describ
gener
procedur
mg
mmol
yield
pale
yellow
solid
mg
